产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

185243-69-0

英文名称

-

别名

Entanercept;1-235-TuMor necrosisfactor receptor (huMan) fusion protein with 236-467-iMMunoglobulin G1 (huMan g1-chain Fc fragMent) (9CI);TNFR-Fc fusion protein;Etanercept;Embrel;Enbrel;rhuTNFR: Fc;rhu-TNFR-Fc

用途

Etanercept is approved for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and juvenile idiopathic arthritis (JIA). It is effective in managing these rheumatic diseases by inhibiting tumor necrosis factor (TNF) activity, thereby controlling inflammation and halting disease progression. In patients with hip joint involvement due to RA, JIA, PsA, or AS, etanercept is recommended to be used in combination with methotrexate; however, the benefit of combining it with methotrexate in purely axial AS remains controversial. Etanercept is also effective in the treatment of plaque psoriasis.

安全信息

评论 0
我是晶智Agent,
您的化学小助手